欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/V/0462/002
药品名称Milprazon 12.5 mg/125.0 mg Tablets for Dogs Weighing At Least 5 kg
活性成分
    • milbemycin A<3>-oxim 12.5 mg
    • PRAZIQUANTEL 125.0 mg
剂型Tablet
上市许可持有人KRKA, d.d. Novo mesto Smarjeska cesta 6 8501 Novo mesto Slovenia
参考成员国 - 产品名称Ireland (IE)
Milprazon 12.5 mg/125 mg tablets for dogs weighing at least 5 kg
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Milprazon 12.5 mg/125.0 mg Tablets for Dogs Weighing At Least 5 kg
    • Germany (DE)
      Milprazon tablets for dogs 12.5 mg + 125 mg
    • Belgium (BE)
      Milprazon 12,5 mg/125 mg
    • Netherlands (NL)
    • Spain (ES)
    • Portugal (PT)
    • Poland (PL)
    • Latvia (LV)
      Milprazon
    • Lithuania (LT)
    • Estonia (EE)
      Milprazon
    • Hungary (HU)
    • Bulgaria (BG)
    • Czechia (CZ)
      Milprazon 12,5 mg/125 mg tablety pro psy o hmotnosti nejméně 5 kg
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
    • France (FR)
      MILPRAZON 12,5 MG/125 MG COMPRIMES POUR CHIENS PESANT AU MOINS 5 KG (14516)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Cyprus (CY)
许可日期2018/04/30
最近更新日期2024/10/07
药物ATC编码
    • QP54AB51 milbemycin oxime, combinations
申请类型
  • TypeLevel1:non-food
  • TypeLevel2:Pharmaceutical
  • TypeLevel3:Other Generic application Art 13.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase